Literature DB >> 27878554

The Involvement of the Decrease of Astrocytic Wnt5a in the Cognitive Decline in Minimal Hepatic Encephalopathy.

Saidan Ding1, Zhu Xu2, Jianjing Yang2, Leping Liu1, Xueli Huang3, Xuebao Wang3, Qichuan Zhuge4.   

Abstract

Wnt signaling plays a key role in neuroprotection and synaptic plasticity. We speculate that the impairment of Wnt signaling may mediate astrocytic neurotrophins (NTs) production and the impairment of Wnt signaling to astrocytic NTs production contributes to the pathogenesis of minimal hepatic encephalopathy (MHE). Here, we found that induction of astrocytic NTs synthesis was by Wnt5a via the calcium/calmodulin-sensitive protein kinase II (CaMK II)-cAMP-response element-binding protein (CREB) pathway in PCAs. The decrease of spatial learning and memory and downregulation of astrocytic BDNF and NT-3 were reversed by Wnt5a in MHE rat model. The increased association between CaMK II and CREB followed by phosphorylation of CREB in response to Wnt5a stimulation was suppressed in the MHE rat model. Our results highlight a novel pathogenesis of the contribution of downregulation of NTs to the inhibition of the interaction between Wnt5a and Frizzled-2 in astrocytes in MHE.

Entities:  

Keywords:  Astrocytes; Cognitive decline; Minimal hepatic encephalopathy; Neurotrophins; Wnt5a-Frizzled-2 signaling

Mesh:

Substances:

Year:  2016        PMID: 27878554     DOI: 10.1007/s12035-016-0216-5

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  37 in total

Review 1.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 2.  Glial specification in the vertebrate neural tube.

Authors:  David H Rowitch
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

3.  CREB: a major mediator of neuronal neurotrophin responses.

Authors:  S Finkbeiner; S F Tavazoie; A Maloratsky; K M Jacobs; K M Harris; M E Greenberg
Journal:  Neuron       Date:  1997-11       Impact factor: 17.173

Review 4.  PDE6 is an effector for the Wnt/Ca2+/cGMP-signalling pathway in development.

Authors:  H Wang; Y Lee; C C Malbon
Journal:  Biochem Soc Trans       Date:  2004-11       Impact factor: 5.407

5.  Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?

Authors:  Alexandre Henriques; Claudia Pitzer; Armin Schneider
Journal:  Front Neurosci       Date:  2010-06-11       Impact factor: 4.677

6.  Differential CaMKII regulation by voltage-gated calcium channels in the striatum.

Authors:  Johanna G Pasek; Xiaohan Wang; Roger J Colbran
Journal:  Mol Cell Neurosci       Date:  2015-08-05       Impact factor: 4.314

7.  Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.

Authors:  Masaoki Kawasumi; Tomohiro Chiba; Marina Yamada; Makiko Miyamae-Kaneko; Masaaki Matsuoka; Jin Nakahara; Taisuke Tomita; Takeshi Iwatsubo; Shigeaki Kato; Sadakazu Aiso; Ikuo Nishimoto; Keisuke Kouyama
Journal:  Eur J Neurosci       Date:  2004-05       Impact factor: 3.386

8.  Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes.

Authors:  F Zafra; D Lindholm; E Castrén; J Hartikka; H Thoenen
Journal:  J Neurosci       Date:  1992-12       Impact factor: 6.167

Review 9.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

10.  Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease.

Authors:  Alan H Nagahara; David A Merrill; Giovanni Coppola; Shingo Tsukada; Brock E Schroeder; Gideon M Shaked; Ling Wang; Armin Blesch; Albert Kim; James M Conner; Edward Rockenstein; Moses V Chao; Edward H Koo; Daniel Geschwind; Eliezer Masliah; Andrea A Chiba; Mark H Tuszynski
Journal:  Nat Med       Date:  2009-02-08       Impact factor: 53.440

View more
  6 in total

1.  κ‑opioid receptor agonist, U50488H, inhibits pyroptosis through NLRP3 via the Ca2+/CaMKII/CREB signaling pathway and improves synaptic plasticity in APP/PS1 mice.

Authors:  Xiaofu Song; Zhiqiang Cui; Jiahuan He; Tuo Yang; Xiaohong Sun
Journal:  Mol Med Rep       Date:  2021-05-26       Impact factor: 2.952

Review 2.  Cognition-tracking-based strategies for diagnosis and treatment of minimal hepatic encephalopathy.

Authors:  Weijia Han; Huanqian Zhang; Ying Han; Zhongping Duan
Journal:  Metab Brain Dis       Date:  2020-06-03       Impact factor: 3.584

Review 3.  Axon Guidance Molecules and Pain.

Authors:  Elisa Damo; Manuela Simonetti
Journal:  Cells       Date:  2022-10-06       Impact factor: 7.666

4.  Celsr3 is required for Purkinje cell maturation and regulates cerebellar postsynaptic plasticity.

Authors:  Qinji Zhou; Jingwen Qin; Yaying Liang; Wei Zhang; Siyuan He; Fadel Tissir; Yibo Qu; Libing Zhou
Journal:  iScience       Date:  2021-07-01

5.  Ketamine administered pregnant rats impair learning and memory in offspring via the CREB pathway.

Authors:  Xinran Li; Cen Guo; Yanan Li; Lina Li; Yuxin Wang; Yiming Zhang; Yue Li; Yu Chen; Wenhan Liu; Li Gao
Journal:  Oncotarget       Date:  2017-05-16

6.  miR-374 improves cerebral ischemia reperfusion injury by targeting Wnt5a.

Authors:  Fangyuan Xing; Yongrong Liu; Ruifang Dong; Ye Cheng
Journal:  Exp Anim       Date:  2020-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.